Sign in
4

Changes in Ownership

AN2 Therapeutics, Inc. Filed Acc 0000950170-23-048436

Director sold 400 shares at $16.00 ($6,400)

From the SEC's structured data for this filing

Trades in this filing

Aziz Kabeer · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-13 Sale : show line 1 in the form −336 $16.00 $5,376 2,177,547 I
2023-09-13 Sale : show line 2 in the form −64 $16.00 $1,024 411,893 I
Open-market sales · 400 sh · avg $16.00 · $6,400
Loading xslF345X05/ownership.xml…